Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device


Diagnostics / Laboratory


Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

Featured Event

save the date

Nov. 10, 2022 | Salt Palace Convention Center | Salt Lake City

Utah Life Sciences by the Numbers

Job Growth

Utah's life sciences industry had the second highest industry annual job growth in the nation from 2019-2020.

Source: Pace, L. and Burton, L., Growth Trends in Utah's Life Sciences Industry, Kem C. Gardner Policy Institute, Univesity of Utah, 2021

Economic Impact

Utah's medical device industry ranks in the top 10 in the nation in three different economic impact metrics, including industry revenues (#8), payroll (#9), and employment (#9).

Source: The Economic Impact o the Medical Technology Industry: A 2021 satistical update on the contributions of the industry ot national and state economic conditions, Advamed, 2021

BioUtah News

September 22, 2022
BioUtah News
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights

Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.

September 15, 2022
BioUtah News
Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December

Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely anticipated Celeste® specialized phototherapy device, PhotoPharmics, today announced plans to begin recruitment for the Celeste Light for PD trial in December. “Multiple forces have aligned to make the timing for […]

September 15, 2022
BioUtah News
nView s1 reaches its 100th surgery

The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation.

September 15, 2022
BioUtah News

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.

September 8, 2022
BioUtah News
Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health

Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent’s goal of changing the course of reproductive health. Inherent seeks to redefine the […]

September 8, 2022
BioUtah News

Last week, BioHive kicked off its celebration of “STEM September” with an evening of networking in downtown Salt Lake City. Life sciences professionals joined from all over the Salt Lake Valley to connect with the industry and support the efforts of BioHive. “I was so inspired hearing stories from the people that make Utah’s life […]

September 8, 2022
BioUtah News Industry News Life Sciences Industry News
Rep. Burgess Owens Spends a Day in the BioHive

Utah life sciences companies took center stage September 2, as U.S. Representative Burgess Owens (R-UT) toured Canyon Labs, Ultradent (Canyon Labs’ parent company), Ortho Development and Xenter – all innovative leaders in advancing medical technologies that improve patient care and provide jobs for hundreds of Utahns. BioUtah helped to facilitate the BioHive day. “Utah is […]

September 1, 2022
BioUtah News
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient

New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications Fluidx Medical announces completion of trial enrollment for its novel embolic device, GPX. In this multi-center trial, GPX was used to treat a variety of primary and metastatic tumors, renal adenoma tumors, and a range […]

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.




Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors